Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Saaimatul Huq

Assistant Staff Scientist

Also affiliated: University of Arkansas Medical Center (2026); National Institute of Biotechnology (2019); Saitama University (2009–2010)

2 h-index 8 pubs 22 cited

  • Animals
  • Humans
  • Pancreatic Neoplasms
  • Radiation Tolerance
  • CDC2 Protein Kinase
  • Carcinoma, Pancreatic Ductal
  • Protein Multimerization
  • Rift Valley fever virus
  • Epitopes, T-Lymphocyte
  • Epitopes, B-Lymphocyte
  • Computational Biology
  • Plant Diseases
  • Plant Viruses
  • Molecular Diagnostic Techniques
  • Ipomoea batatas

Biography and Research Information

OverviewAI-generated summary

Saaimatul Huq's research has focused on several distinct areas, including molecular biology, virology, and cancer therapeutics. Recent publications highlight work on the immunoinformatic investigation of Rift Valley fever virus protein to identify potential vaccine epitopes and the enhanced radiosensitivity of pancreatic cancer through the inhibition of Cyclin-dependent kinase 1. Huq has also contributed to studies involving molecular techniques for detecting plant viruses and the genome-wide identification of protein phosphatase 2C genes in sweet potato.

Further research interests include CRISPR-mediated correction of oncogenic AS-NMD in splicing factor mutant cancer and targeting SETD2 in combination with radiotherapy for rectal cancer. Huq has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Adam R. Wolfe and Lokesh Akana, with whom they share multiple publications. Their work reflects a broad engagement with fundamental biological processes and their application to health and agricultural challenges.

Metrics

  • h-index: 2
  • Publications: 8
  • Citations: 22

Positions

  • Assistant Staff Scientist 2026–present
    University of Arkansas for Medical Sciences Biochemistry and Molecular Biology ORCID
  • Postdoctoral Fellow 2023–2026
    University of Arkansas for Medical Sciences Radiation Oncology ORCID
  • Research Associate Scientist 2022–2023
    Toronto Metropolitan University Department of Chemistry and Biology ORCID

Selected Publications

  • CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer (2026)
    bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
  • Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer (2025)
    Molecular Cancer Therapeutics DOI OpenAlex
  • Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction (2025)
    Research Square DOI OpenAlex
  • Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024)
    Cancer Research DOI OpenAlex
  • Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1 (2024)
    Radiotherapy and Oncology 6 citations DOI OpenAlex
  • An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines (2024)
    The Journal of Infection in Developing Countries 2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

26 Collaborators 4 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics